NSAMembers

 

Originally founded as a subsidiary wholly owned by Neurosciences Victoria, Neurosciences Australia Ltd underwent a significant change in the 2004-05 year, with both the South Australian Neuroscience Institute (SANI) and the University of Tasmania formally joining as members, and thus part-owners, of the company.

In addition, the contribution and ongoing support of the NNF by the research institutes that participated, with Neurosciences Victoria, in the original application to the Commonwealth Government’s Major National Research Facilities Program, is acknowledged and greatly appreciated. These institutes are the:

Howard Florey Institute
Genomic Disorders Research Centre
Mental Health Research Institute
National Muscular Dystrophy Research Centre



South Australian Neuroscience Institute (SANI)


SANI represents the vast majority of Neuroscientists in South Australia. Many members of SANI are internationally recognised neuroscience researchers, who have maintained a record of success in securing funds from peer-reviewed national and international granting bodies and from industry. SANI includes 45 Neuroscience laboratories and more than 100 members and almost 200 research students. Collectively the SANI laboratories attract more than $10 million per year. Most laboratories involve collaboration of scientists from different disciplines within South Australia, and most also have multiple state, national and international collaborations.

SANI is recognised and supported by the three Universities in South Australia and, through Flinders University, joined NSA in 2004. In 2004 SANI obtained funding from the Premier’s Science and Research Fund to develop a business plan. This now has been completed and SANI is in the process of implementing the recommendations. Its interim structure includes a broad membership, a steering committee and an executive composed of two co-chairs (Marcello Costa and Robert Vink), a secretary (Simon Brookes) and a treasurer (Robert Rush). A steering committee representing all Institutions and most sub-disciplines has provided the necessary guidance in establishing a functional SANI organization.

The major aims of SANI include fostering in South Australia neuroscience-related research, education, services and commercialisation. The main activities to fulfil these aims have been coordinating public lectures, scientific symposia and applications for research and infrastructure funding, including submissions to NCRIS (via SA and via NSA) and to the Research Scheme “Thinking Systems” as well as participation in an application for a CRC for Learning.

In the field of education, SANI has developed and launched a Graduate Certificate in Neuroscience for teachers and other professionals in South Australia, in collaboration with the Department of Education and Social Services (DESS). The course will start in 2006 and involves a true collaboration between many neuroscientists from all three Universities. Public education has been fostered by organising events under Brain Awareness Week, participating in the activities of South Australian Government scheme “Science outside the Square” (SOS), and by establishing links with the newly formed Physical and Neurological Council of South Australia (PNCSA), an umbrella organization for most patient groups in South Australia relevant to Neuroscience.


University of Tasmania

Neuroscience researchers at the University of Tasmania (UTas) have research programs that are focused on a range of diseases and conditions that affect the nervous system. Research spans fundamental studies of nerve cell biology to the development of new therapeutic drugs and other interventions for human disease. Research covers the major forms of human brain degeneration, including Alzheimer’s disease, Parkinson’s disease, Motor Neuron disease, stroke and brain and spinal cord injury.

UTas researchers have made a major contribution towards understanding how nerve cells degenerate and die in Alzheimer’s disease. This investigation has provided a causal link between the pathological changes that occur within the brains of Alzheimer’s disease sufferers and has identified the earliest nerve cell changes that lead to dementia. Therapeutic approaches for neurodegeneration currently under investigation include the development of a proteinbased agent with neuroprotective and regenerative abilities, cell-based therapies for spinal cord injury and physical therapies targeted at supporting brain plasticity. The development of new therapeutic agents has followed from the establishment of novel in vitro techniques with mature nerve cells and involving, for example, axon injury, axon stretch, excitotoxicity and chronic oxidative stress.

Tasmanian researchers are also active in studies on the development, organisation and plasticity of the nervous system. A number of laboratories are focused on proteins and signals that are involved in nervous system development. Researchers at UTas are also interested in how nerve cells respond to injury and have demonstrated that specific types of mature nerve cells have the capacity to regenerate following damage. These studies have involved live imaging and multiple fluorescence labelling to visualise the regenerative properties of neurons. Another group of Tasmanian researchers are focused on mapping and measuring electrical activity of the human brain. These studies are providing new insight into higher functions of the brain, including how we attend to specific features of our environment.


Neurosciences Victoria

Neurosciences Victoria (NSV) led the application for the MNRF grant and provides management services to the NNF under a contract with Neurosciences Australia Ltd. NSV is a membership-based organisation.
Its members include the:

Brain Research Institute
Centre for Eye Reseach Australia
Howard Florey Institute
Mental Health Research Institute
Monash University
National Stroke Research Institute
Swinburne University
University of Melbourne

NSV’s Mission
NSV is dedicated to the continued development of the world-class neuroscience biocluster in Melbourne, Australia through a program of strategic investment in the gap between academic discovery research and commercial development.
By providing focus and direction for neuroscience research and through the creation and development of strong industry partnerships, NSV provides a unique and effective interface between neuroscientists, the biotechnology and pharmaceutical industries, investors and public funding bodies.

Why NSV?
NSV represents a number of leading neuroscience research institutes, offering access to research programs in Pain, Epilepsy, Neurodegeneration (Alzheimer’s disease, Parkinson’s disease & ALS), Stroke, Neural & Muscle Regeneration and Mental Health. A select portfolio of IP generated within these programs is available for potential out licensing or co-development.
In addition, NSV specialises in the creation and management of large-scale, multi-centre contract research agreements, based on the excellent research infrastructure, skills and expertise within our membership base.
NSV also promotes the integrated set of infrastructure, facilities and expertise available through the NNF to potential clients both nationally and internationally.